Clinical Trial Update: IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating intravenous gallium in cystic fibrosis patients with nontuberculous mycobacterial infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Nontuberculous Mycobacterial Infection

Drugs mentioned

• IV Gallium (gallium)

Snippet

Sponsor: Chris Goss | Conditions: Nontuberculous Mycobacterium Infection | Phase 1 | Status: RECRUITING